POCOR: Cognitive Trajectories After Surgery, a Clinical, Observational Feasibility Study

Sponsor
Karolinska Institutet (Other)
Overall Status
Recruiting
CT.gov ID
NCT05564195
Collaborator
Ersta Hospital, Sweden (Other)
50
1
10.7
4.7

Study Details

Study Description

Brief Summary

Research problem and specific questions: Approximately 2.8 million surgeries are conducted yearly in Sweden and of these almost 50% are persons ≥ 60 years. Postoperative cognitive recovery is a concern for older persons. To date, there is no evidence for treating postoperative neurocognitive decline (POCD) and no assessment of cognitive function is routinely performed. The purpose is to is to test digital monitoring in clinical practice: I) test recruitment process and measure attrition rate; II) estimate the difference in main clinical outcomes (POCD) that will inform sample size calculations for the longitudinal observational mixed methods study, III) determine the usability and feasibility of digital monitoring. Participants: 50 patients ≥60 years undergoing inpatient surgery. Outcomes: depression, frailty, cognitive function, postoperative recovery and functional status .

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Postoperative cognitive function

Detailed Description

The aim is to evaluate the digital cognitive monitoring (Mindmore-P) in clinical practice by:
  1. Test recruitment process and measure attrition rate. II) To establish whether it is possible to detect early signs of neurocognitive decline, using a digital postoperative cognitive screening tool i.e. Mindmore-P.

  2. To investigate if there are any associations between choice of anesthetic drugs, delirium, duration of anesthesia, preoperative frailty, depression symptoms, postoperative delirium, physical function, and early postoperative recovery.

  3. Determine the usability and feasibility of Mindmore-P. V) Determine patients' experiences of early cognitive recovery in relation to signs of cognitive decline or no signs measured bythe four tests included in Mindmore-P

METHODS AND ANALYSIS Study design This is an observational feasibility study.

Participants included will be patients undergoing planned non-cardiac surgery with general anesthesia (n=50) at a hospital in Stockholm, Sweden. The sample size is based on the incidence of early cognitive decline at 1-2 weeks postoperatively of approximately 13-25%.

Inclusion criteria:
  1. 60 years of age undergoing elective non-cardiac surgery with general anesthesia.

  2. Duration of surgery >60 minutes

  3. Mini-mental state examination (MMSE) score >24.

Exclusion criteria:
  1. Unable to read and speak Swedish

  2. Uncorrected severe visual or auditory disorder, disease of the central nervous system, psychiatric diseases including alcoholism or drug dependence, current motor impairment in dominant hand, or colour-blindness.

Recruitment At the patient's preoperative anaesthesia consultation, a research nurse will provide oral and written information about the study. The details of the study and its potential benefits as well as risks will be explained carefully to the patient. If the patient agrees to participate in the study, they will undergo a MMSE screening to examine if they are eligible for the study.

Outcomes, look below.

Analysis Descriptive statistics of demographic data will be presented with number, percentage, and mean (sd) or min-max, as appropriate. As recommended by Borchers et al review from 2021, mild POCD (1-2 standard deviation [sd]) and major POCD (>2 sd) will be specified for each test result and POCD is present if at least two tests indicates decline.

Usability and attrition rates will be presented with descriptive statistics. Preoperative depression (GDS), frailty (CFS), postoperative recovery (SwQoR), functional status (WHODAS) will be compared between the groups, using Kruskal Wallis ANOVA followed by Mann-Whitney U-test and a Bonferroni correction. To analyse intraindividual differences over time in cognitive performance, the same statistical tests will be used as well as multivariate logistic regression analysis. A p-value of <0.05 will be statistically significant in all analyses, Qualitative data will be analysed with thematic analysis.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Cognitive Trajectories After Surgery, a Clinical, Observational Feasibility Study
Actual Study Start Date :
Jan 10, 2023
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients undergoing elective surgery with a duration of > 60 minutes

Participants included will be patients undergoing planned non-cardiac surgery with general anesthesia that are >60 years of age, have a Mini-mental state examination score of >24, are able to speak Swedish and does not suffer from uncorrected severe visual or auditory disorder, disease of the central nervous system, psychiatric diseases including alcoholism or drug dependence, current motor impairment in dominant hand, or colour-blindness.

Diagnostic Test: Postoperative cognitive function
Digital cognitive tests - Mindmore-P, will be used to assess neurocognitive capacity and includes tests of verbal episodic memory, executive functions, visuospatial function and attention. The cognitive tests are self-administered on a touch screen tablet (10.1" 20-30 min Windows). The Mindmore-P is a web-application running on a full-screen Chrome browser. The test is administered by using a capacitive touchscreen with features that record detailed information such as timing, pauses, and lifting of finger from the touchscreen. Speech recognition is used in the screening of verbal memory and language.

Outcome Measures

Primary Outcome Measures

  1. Recruitment process and attrition rate [Through study completion, an average of 8 months]

    Number of possible participants vs. number of participants who accept to participate and number of participants who complete the study

  2. Changes in postoperative cognitive function, part 1 [Before surgery and day 1 or 2, and 3 weeks after surgery]

    Consortium to Establish a Registry for Alzheimer´s Disease (CERAD) A 10-word verbal learning test with 3 learning trials, a recall trial after ~7 min.

  3. Changes in postoperative cognitive function, part 2 [Before surgery and day 1 or 2, and 3 weeks after surgery]

    Trail Making Test (TMT- A & B), consisting of of 25 circles with letters or numbers on the screen. 4. Symbol Digits Processing Test (SDPT).The test consist of nine symbol-digit pairings at the top of the screen, one symbol in the middle of the screen, and a number grid at the bottom of the screen.

  4. Changes in postoperative cognitive function, part 3 [Before surgery and day 1 or 2, and 3 weeks after surgery]

    Stroop Colour-Word Test (SCW). 24 words spelling out a the name of a colour which is printed in contrasting ink colours (e.g., the word "green" printed with red ink), and the participant is asked to tell the printed colour of the word rather than the word rather than the actual meaning of the word.

  5. Changes in postoperative cognitive function, part 4 [Before surgery and day 1 or 2, and 3 weeks after surgery]

    Symbol Digits Processing Test (SDPT).The test consist of nine symbol-digit pairings at the top of the screen, one symbol in the middle of the screen, and a number grid at the bottom of the screen.

Secondary Outcome Measures

  1. Frailty [Before surgery]

    Clinical Frailty Scale, including 9-item ranging from 1 - very vital to 9 - terminally ill.

  2. Signs of and changes in depression [Before surgery and 3 weeks after surgery]

    Geriatric Depression Scale (GDS), consisting of 15 items to be answered with Yes or No. A score of 5 to 10 indicates probable depression and a score of more than 10 indicates definite depression.

  3. Changes in functional capacity [Before surgery and 3 weeks after surgery]

    World Health Organization Disability Assessment Schedule 2.0 (WHODAS), thats consists of 12-item. Sum score ranges from 0-48, with increasing scores reflecting increasing disability

  4. Changes in postoperative recovery [Before surgery and day 1 or 2, and 3 weeks after surgery]

    Swedish version of Quality of Recovery, SwQoR, including 24 different postoperative symptoms to be rated on 11-point numerical scales from 0, "none of the time", to 10, "all of the time" Global score ranging from 0, "excellent quality of postoperative recovery," to 240, "extremely poor quality of recovery," with cutoff values of less than 31 at day 7 and less than 21 at day 14 indicating good recovery

  5. Usability of Mindmore-P [3 weeks after surgery]

    System Usability Scale (SUS), consisting of 10 items to be answered on a 5-point scale from "strongly agree" to "strongly disagree".

  6. Feasibility and patients' experiences of early postoperative cognitive recovery [One month after surgery]

    Semi-structured, one-on-one interviews exploring patients' experiences of being assessed for cognitive performance and using Mindmore-P including assessment of facilitators and barriers, will be conducted. The participants will be asked to communicate freely on their experiences of their postoperative recovery.

  7. Signs of and changes in postoperative delirium [After surgery twice a day on postoperative day 1-2]

    Nursing Delirium Screening Scale NU-DESC, an observational five-item scale where symptoms delirium are rated from 0 to 2. A score of 2 or more indicates delirium

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 60 years of age undergoing elective non-cardiac surgery with general anesthesia.

  • Duration of surgery >60 minutes

  • Mini-mental state examination score >24.

Exclusion Criteria:
  • Mini-mental state examination, cut-off score of <23 indicating cognitive impairment

  • Unable to read and speak Swedish

  • Uncorrected severe visual or auditory disorder,

  • Disease of the central nervous system

  • Psychiatric diseases

  • Alcoholism or drug dependence

  • Current motor impairment in dominant hand

  • Colour-blindness.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ulrica Nilsson Stockholm Sweden 141 83

Sponsors and Collaborators

  • Karolinska Institutet
  • Ersta Hospital, Sweden

Investigators

  • Principal Investigator: Ulrica Nilsson, Professor, Karolinska Insitutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ulrica Nilsson, Professor, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT05564195
Other Study ID Numbers:
  • 2022-03593-01
First Posted:
Oct 3, 2022
Last Update Posted:
Jan 26, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2023